Stem Cells
& Exosomes
& Exosomes
Research and Development
World’s first ATMP approved Stem Cells and Exosomes
ADVANCED THERAPY MEDICINAL PRODUCT
Cell-based Regenerative medicine
Regenerative medicine is a field that aims to restore or establish normal function in damaged tissues and organs. Stem cells and exosomes are two key therapeutic strategies within this ever-evolving field. Stem cells are cells with the ability to develop into various cell types, aiding in tissue repair and regeneration. Exosomes are small extracellular vesicles that facilitate cell-to-cell communication and can influence biological processes such as cell proliferation and differentiation. Both therapies offer unique advantages and challenges, and ongoing research continues to explore their full therapeutic potential.
Stem Cells Therapy
Stem cell therapy is one of the most promising areas in regenerative medicine. It involves using stem cells to treat or prevent a disease or condition. Over the next decade, advancements in stem cell research are expected to lead to more effective and targeted treatments for a variety of diseases, including Parkinson's, Alzheimer's, and certain types of cancer.
Exosomes Therapy
Exosome therapy is an emerging regenerative medicine approach that harnesses the body's natural cellular communication processes to promote healing and tissue regeneration. Exosomes are tiny, membrane-bound sacs (30-150 nanometers) released by nearly all cells. They function as natural couriers, transporting proteins, lipids, and genetic material like RNA between cells. This intercellular communication plays a role in biological processes such as immune responses, inflammation, and tissue repair.
About Us
anmhealth is a leading organization dedicated to advancing healthcare through innovative solutions and research. We specialize in providing source materials like cord blood, umbilical cord tissue, and adult single cells, while offering advanced product solutions including stem cells, natural killer (NK) cells, exosomes, and peptides. Our expertise extends to product research with ATMP blood/tissue banks and cGMP labs, as well as discovery research in life sciences, characterization analysis, and safety/toxicity testing. Committed to excellence, we bridge science and health to drive impactful medical advancements.
Umbilical Cord Stem Cells
Umbilical cord stem cells are valuable for their potential in treating various diseases and medical conditions, and they are collected from the umbilical cord and placenta of healthy live deliveries after childbirth.
Umbilical cord stem cells are multipotent stem cells derived from the umbilical cord, specifically from the cord blood and tissue. These cells have the ability to differentiate into various cell types, such as blood cells, nerve cells, and cartilage, making them valuable in regenerative medicine. They are rich in hematopoietic stem cells (which form blood and immune cells) and mesenchymal stem cells (which can develop into bone, cartilage, and fat cells). Collected non-invasively after birth, they are widely used due to their ethical sourcing and lower risk of immune rejection compared to other stem cell types.
Potential Therapy Applications:
Immune System Disorders: Management of conditions like severe combined immunodeficiency (SCID).
Regenerative Medicine: Repair of damaged tissues in conditions such as spinal cord injuries, heart disease, and cartilage degeneration.
Neurological Conditions: Potential therapy for cerebral palsy, autism, and traumatic brain injuries.
Autoimmune Diseases: Supportive treatment for multiple sclerosis and lupus.
Organ Repair: Aid in liver and kidney regeneration or repair.
Research is ongoing to expand their therapeutic scope, with clinical trials exploring additional applications.
Regenerative Medicine: Repair of damaged tissues in conditions such as spinal cord injuries, heart disease, and cartilage degeneration.
Neurological Conditions: Potential therapy for cerebral palsy, autism, and traumatic brain injuries.
Autoimmune Diseases: Supportive treatment for multiple sclerosis and lupus.
Organ Repair: Aid in liver and kidney regeneration or repair.
Research is ongoing to expand their therapeutic scope, with clinical trials exploring additional applications.
Wharton’s jelly Exosomes
Wharton's Jelly exosomes are of great interest to doctors in regenerative medicine due to their unique properties. They carry bioactive molecules that promote tissue repair, reduce inflammation, and modulate the immune response, offering a cell-free alternative to traditional stem cell therapies. Their small size allows for easy delivery to damaged tissues, and their low immunogenicity reduces the risk of rejection. Additionally, being derived from a readily available and ethically sourced material (umbilical cord Wharton's jelly), they provide a scalable and safe option for treating conditions like cardiovascular diseases, neurodegenerative disorders, and orthopedic injuries, making them a promising tool for advancing patient outcomes.
Wharton's Jelly exosomes are small extracellular vesicles derived from the mesenchymal stem cells (MSCs) found in Wharton's jelly, a gelatinous substance within the umbilical cord. These exosomes are rich in bioactive molecules such as proteins, lipids, and genetic material (e.g., mRNA and microRNA), which enable cell-to-cell communication and tissue repair. They are considered a promising cell-free therapeutic option due to their regenerative, anti-inflammatory, and immunomodulatory properties, avoiding the risks associated with whole-cell therapies.
Potential Therapy Applications:
- Tissue Regeneration: Promotion of wound healing and repair of damaged skin, muscles, and tendons
- Cardiovascular Diseases: Support for heart tissue repair post-myocardial infarction and reduction of inflammation
- Neurodegenerative Disorders: Potential treatment for Alzheimer's, Parkinson's, and stroke recovery by reducing neuroinflammation
- Autoimmune Conditions: Management of rheumatoid arthritis and multiple sclerosis through immunomodulation
- Orthopedic Injuries: Aid in cartilage and bone repair, including osteoarthritis treatment
- Cancer Therapy: Enhancement of anti-tumor immunity or drug delivery in targeted cancer treatments
Frequently Asked Questions
Our umbilical cord stem cells are mesenchymal stem cells (MSCs) derived from donated umbilical cords, providing 100 million MSCs per vial in a frozen format for optimal preservation and viability.
What are umbilical cord stem cells?
Umbilical cord stem cells, specifically mesenchymal stem cells (MSCs), are multipotent cells harvested from the umbilical cord tissue of healthy, full-term births. These cells have the potential to differentiate into various cell types, such as bone, cartilage, and muscle cells, and are known for their regenerative properties.
How are your umbilical cord stem cells sourced and processed?
Our MSCs are ethically sourced from donated umbilical cords with full consent from donors. The cords are collected under sterile conditions and processed in our state-of-the-art ATMP-certified facilities. Each vial contains 100 million viable MSCs, cryopreserved in a frozen format to maintain potency during storage and transport.
What is the storage and handling requirement for the frozen vials?
The vials should be stored in ultra-low temperature freezer at -80°C until ready for use. Upon thawing, they must be handled according to our provided protocols to ensure cell viability. We recommend consulting with a qualified healthcare professional for administration.
Are umbilical cord stem cells safe?
Yes, our umbilical cord MSCs are rigorously tested for safety, including sterility, endotoxin levels, and absence of infectious agents. They are produced in compliance with EMA guidelines for human cellular and tissue-based products. As with any medical product, individual responses may vary, and we advise use under medical supervision to minimize risks.
What can I expect from treatment with umbilical cord stem cells?
Treatments using MSCs may support tissue repair, reduce inflammation, and promote regeneration in conditions like orthopedic injuries, autoimmune disorders, or degenerative diseases. Patients often report improvements in pain, mobility, and overall function, though results depend on individual health factors, dosage, and administration method. Clinical outcomes should be discussed with your healthcare provider.
Are there any side effects or risks associated with stem cell treatments?
Common side effects are minimal and may include temporary injection site reactions, mild fever, or fatigue. Rare risks could involve immune responses or infection if not administered properly. Our products undergo extensive quality controls to mitigate these, but always consult a physician for personalized risk assessment.
How effective are umbilical cord stem cells?
Efficacy varies by application and patient condition. Research and clinical studies suggest MSCs can modulate immune responses and aid in tissue healing. While promising, stem cell therapies are not a guaranteed cure, and ongoing research continues to explore their full potential.
Is this product regulated?
Yes, our umbilical cord stem cells are manufactured in accordance with EU EMA guidelines and standards Advanced Therapy Medicinal Products as governed by the Ministry of Health in the country of production. ATMP-grade stem cells standards and are intended for research and therapeutic use under appropriate regulatory approvals in Europe. They are not approved for all indications, so verify compliance with your own local regulations.
What are umbilical cord stem cells?
Umbilical cord stem cells, specifically mesenchymal stem cells (MSCs), are multipotent cells harvested from the umbilical cord tissue of healthy, full-term births. These cells have the potential to differentiate into various cell types, such as bone, cartilage, and muscle cells, and are known for their regenerative properties.
How are your umbilical cord stem cells sourced and processed?
Our MSCs are ethically sourced from donated umbilical cords with full consent from donors. The cords are collected under sterile conditions and processed in our state-of-the-art ATMP-certified facilities. Each vial contains 100 million viable MSCs, cryopreserved in a frozen format to maintain potency during storage and transport.
What is the storage and handling requirement for the frozen vials?
The vials should be stored in ultra-low temperature freezer at -80°C until ready for use. Upon thawing, they must be handled according to our provided protocols to ensure cell viability. We recommend consulting with a qualified healthcare professional for administration.
Are umbilical cord stem cells safe?
Yes, our umbilical cord MSCs are rigorously tested for safety, including sterility, endotoxin levels, and absence of infectious agents. They are produced in compliance with EMA guidelines for human cellular and tissue-based products. As with any medical product, individual responses may vary, and we advise use under medical supervision to minimize risks.
What can I expect from treatment with umbilical cord stem cells?
Treatments using MSCs may support tissue repair, reduce inflammation, and promote regeneration in conditions like orthopedic injuries, autoimmune disorders, or degenerative diseases. Patients often report improvements in pain, mobility, and overall function, though results depend on individual health factors, dosage, and administration method. Clinical outcomes should be discussed with your healthcare provider.
Are there any side effects or risks associated with stem cell treatments?
Common side effects are minimal and may include temporary injection site reactions, mild fever, or fatigue. Rare risks could involve immune responses or infection if not administered properly. Our products undergo extensive quality controls to mitigate these, but always consult a physician for personalized risk assessment.
How effective are umbilical cord stem cells?
Efficacy varies by application and patient condition. Research and clinical studies suggest MSCs can modulate immune responses and aid in tissue healing. While promising, stem cell therapies are not a guaranteed cure, and ongoing research continues to explore their full potential.
Is this product regulated?
Yes, our umbilical cord stem cells are manufactured in accordance with EU EMA guidelines and standards Advanced Therapy Medicinal Products as governed by the Ministry of Health in the country of production. ATMP-grade stem cells standards and are intended for research and therapeutic use under appropriate regulatory approvals in Europe. They are not approved for all indications, so verify compliance with your own local regulations.
Our Wharton's Jelly exosomes are derived from the gelatinous tissue within the umbilical cord, offering 100 billion exosomes per vial in a lyophilized (freeze-dried) format for easy reconstitution and stability.
What are Wharton's Jelly exosomes?
Exosomes are small extracellular vesicles secreted by cells, acting as messengers to transfer proteins, lipids, and genetic material between cells. Our exosomes are isolated from Wharton's Jelly, the connective tissue in umbilical cords, and are rich in bioactive molecules that support cellular communication and regeneration.
How are your Wharton's Jelly exosomes sourced and processed?
They are sourced from donated umbilical cords, processed through advanced isolation techniques in our ATMP-certified labs. Each vial contains 100 billion exosomes, lyophilized for long-term stability without refrigeration, allowing easy reconstitution with sterile saline before use.
What is the storage and handling requirement for the lyophilized vials?
Lyophilized vials can be stored at room temperature (15-30°C) in a dry, dark place for up to 24 months. Once reconstituted, they should be used immediately or stored refrigerated for short periods as per our guidelines. Professional handling is recommended.
Are Wharton's Jelly exosomes safe?
Yes, our exosomes are extensively purified and tested for purity, potency, and safety, including freedom from contaminants and pathogens. They comply with relevant regulatory standards. As non-cellular products, they pose a low risk of immune rejection, but administration should be overseen by a healthcare professional.
What can I expect from treatment with Wharton's Jelly exosomes?
Exosome treatments may enhance cellular repair, reduce inflammation, and promote anti-aging effects in applications like skincare, wound healing, or joint health. Patients might notice improved skin texture, reduced pain, or faster recovery, though individual results vary based on treatment protocol and health status.
Are there any side effects or risks associated with exosome treatments?
Side effects are generally rare and mild, such as temporary redness or swelling at the application site. Risks are minimized due to their acellular nature, but improper use could lead to allergic reactions. Always discuss with a medical expert for safe application.
How effective are Wharton's Jelly exosomes?
Studies indicate exosomes can facilitate intercellular signaling for therapeutic benefits, such as in regenerative medicine. Their effectiveness depends on the condition treated and dosage. While research is promising, exosomes are not a universal solution, and efficacy should be evaluated through clinical evidence.
Is this product regulated?
Our exosomes are produced under cGMP standards and are suitable for research or clinical use where permitted. They may fall under varying regulations depending on the intended application, so ensure alignment with FDA or equivalent guidelines in your region.
What are Wharton's Jelly exosomes?
Exosomes are small extracellular vesicles secreted by cells, acting as messengers to transfer proteins, lipids, and genetic material between cells. Our exosomes are isolated from Wharton's Jelly, the connective tissue in umbilical cords, and are rich in bioactive molecules that support cellular communication and regeneration.
How are your Wharton's Jelly exosomes sourced and processed?
They are sourced from donated umbilical cords, processed through advanced isolation techniques in our ATMP-certified labs. Each vial contains 100 billion exosomes, lyophilized for long-term stability without refrigeration, allowing easy reconstitution with sterile saline before use.
What is the storage and handling requirement for the lyophilized vials?
Lyophilized vials can be stored at room temperature (15-30°C) in a dry, dark place for up to 24 months. Once reconstituted, they should be used immediately or stored refrigerated for short periods as per our guidelines. Professional handling is recommended.
Are Wharton's Jelly exosomes safe?
Yes, our exosomes are extensively purified and tested for purity, potency, and safety, including freedom from contaminants and pathogens. They comply with relevant regulatory standards. As non-cellular products, they pose a low risk of immune rejection, but administration should be overseen by a healthcare professional.
What can I expect from treatment with Wharton's Jelly exosomes?
Exosome treatments may enhance cellular repair, reduce inflammation, and promote anti-aging effects in applications like skincare, wound healing, or joint health. Patients might notice improved skin texture, reduced pain, or faster recovery, though individual results vary based on treatment protocol and health status.
Are there any side effects or risks associated with exosome treatments?
Side effects are generally rare and mild, such as temporary redness or swelling at the application site. Risks are minimized due to their acellular nature, but improper use could lead to allergic reactions. Always discuss with a medical expert for safe application.
How effective are Wharton's Jelly exosomes?
Studies indicate exosomes can facilitate intercellular signaling for therapeutic benefits, such as in regenerative medicine. Their effectiveness depends on the condition treated and dosage. While research is promising, exosomes are not a universal solution, and efficacy should be evaluated through clinical evidence.
Is this product regulated?
Our exosomes are produced under cGMP standards and are suitable for research or clinical use where permitted. They may fall under varying regulations depending on the intended application, so ensure alignment with FDA or equivalent guidelines in your region.
ANM Health LLC
Dubai, United Arab Emirates
Tel: +971 58 58 73 979
Email: info@anmhealth.com
Dubai, United Arab Emirates
Tel: +971 58 58 73 979
Email: info@anmhealth.com
DISCLAIMER
This product is being sold for research use only and has not been evaluated by the U.S. Food and Drug Administration for safety or efficacy in humans. ANM Health LL and its CDMO manufacturer make no representations regarding the effectiveness of this product in treating human disease. This product is not intended to diagnose, treat, cure, or prevent any disease. Any research use of this product must follow applicable federal regulations included but not limited to the Code of Federal Regulations title 21. It is the responsibility of individual customers to design and perform their research studies in compliance with applicable statutes and regulations.
ANM Health LLC produces exosomes for research use only. This product is not intended for clinical use. There are currently no active clinical trials of ANM Health products. We plan to pursue the clinical development of our products once we file an Investigational New Drug (IND) application with the FDA and our application is approved. Products are not sold directly to consumers.
This product is being sold for research use only and has not been evaluated by the U.S. Food and Drug Administration for safety or efficacy in humans. ANM Health LL and its CDMO manufacturer make no representations regarding the effectiveness of this product in treating human disease. This product is not intended to diagnose, treat, cure, or prevent any disease. Any research use of this product must follow applicable federal regulations included but not limited to the Code of Federal Regulations title 21. It is the responsibility of individual customers to design and perform their research studies in compliance with applicable statutes and regulations.
ANM Health LLC produces exosomes for research use only. This product is not intended for clinical use. There are currently no active clinical trials of ANM Health products. We plan to pursue the clinical development of our products once we file an Investigational New Drug (IND) application with the FDA and our application is approved. Products are not sold directly to consumers.
Information
Privacy Statement
Privacy Statement
Resources
Home
About Us
Home
About Us
Location
Dubai,UAE
Contact
Dubai,UAE
Contact
